The future of medicine
begins with a root.
Equatoria Biosciences builds a sustainable, pharmaceutical-grade supply chain for African botanicals — with a primary focus on Voacangaand root-derived alkaloids for licensed medical research.
A stronger foundation for botanical medicine. Built across Africa.
Equatoria works with multiple cultivation partners across Africa, with a primary focus on Voacanga africana and other botanicals relevant to pharmaceutical and neurological research. This diversified model supports resilient supply while keeping origin, quality, and stewardship visible at every stage.
Each partner relationship is developed around sustainable cultivation, fair participation, responsible harvest planning, and documentation that can follow root material from its source to a verified research laboratory.
- Multiple cultivation partners across Africa
- Voacanga-forward sourcing strategy
- Capacity to export up to 1,000 kg of root monthly
- Documented chain of custody from root to laboratory
A bridge between African pharmacognosy and modern frontier medicine.
For centuries, African botanicals have been studied for their extraordinary properties. Today, alkaloids found in the root and root bark of species such as Voacanga and iboga are being investigated by neuroscientists for their potential in addiction medicine and neurological research.
Equatoria Biosciences exists to make that research possible. We connect responsible African cultivation partners with laboratories defining what comes next in medicine, without overstating regulatory status or the scope of any single partnership.
Built across Africa
Multiple cultivation partners create a resilient supply network while preserving visibility into origin and stewardship.
Built with the land
We prioritize responsible harvest planning, fair partner relationships, and cultivation practices suited to each botanical's ecosystem.
Institutional supply
We work with licensed research institutions advancing peer-reviewed botanical, ibogaine, and neurological science.
A molecule rewriting the rules of neurological medicine.
From Stanford to São Paulo, peer-reviewed studies are investigating ibogaine, noribogaine, and related compounds as potential breakthrough therapies for opioid-use disorder, traumatic brain injury, depression, and PTSD.
Ready to advance your research?
We work with licensed research institutions. Reach out to discuss supply, documentation, and timelines for your program.
Contact Equatoria